Immutable evidence record · ticker

Celyad Oncology SA (CYAD)

Published as observed on 17 August 2026 at 02:25 BST.

Celyad Oncology SA has a balanced company news read. Its latest completed weekly trend is negative.

As of
17 Aug 2026, 02:25
Scope
company and instrument
Evidence
3 items
Independent sources
1
Country
Belgium
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Celyad Oncology SA (CYAD), 2026-08-17, https://sharemaestro.com/evidence/455b11bd-724c-465a-a87b-12d31859ead9/
Record checksum 6609c67b64b3091275076bec0e8d7b28c0ebd22d86f8b0905a6274ea4b4daa0f

Evidence context